UPDATE: Valeant Pharma (VRX) Exploring Sale of Eye-Surgery Equipment Business - DJ

November 2, 2016 2:48 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

(Updated - November 2, 2016 2:50 PM EDT)

Valeant Pharma (NYSE: VRX) is exploring a sale of its eye-surgery equipment business, according to Dow Jones, citing source.

The unit could fetch $2.5 billion, the report said, though discussions are still preliminary.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Hot M&A, Mergers and Acquisitions, Rumors, Trader Talk

Add Your Comment